It’s the ultimate leverage play.
Out of nowhere, Emerald Health Therapeutics Inc. (TSX.V: EMH) just announced its intention to become a dominant player in Canada’s industrial-scale cannabis cultivation business.
Not only does the company plan to scale-up in a big way and on an expedited timeline, but it also intends to become the industry’s lowest-cost producer.
This all amounts to an extremely ambitious value proposition. However, Emerald Health believes it has found a relatively low-cost, low-risk route to becoming an industry leader.
Article by: Marc Davis on Stockhouse